Tarsus Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 38.2M shares, a 15.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 38.2M +5.12M +15.5% Nov 7, 2024 10-Q 2024-11-13
Q2 2024 38M +5.43M +16.6% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 37.8M +11.1M +41.3% May 2, 2024 10-Q 2024-05-08
Q3 2023 33.1M +6.43M +24.1% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 32.6M +5.96M +22.4% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 26.7M +6.02M +29.1% Mar 9, 2023 10-K 2023-03-17
Q3 2022 26.7M +6M +29% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 26.7M +6.08M +29.6% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 20.7M +206K +1% Mar 9, 2022 10-K 2022-03-14
Q3 2021 20.7M Nov 4, 2021 10-Q 2021-11-10
Q2 2021 20.6M Aug 1, 2021 10-Q 2021-08-05
Q1 2021 20.5M Mar 19, 2021 10-K 2021-03-31
Q4 2020 20.3M Nov 23, 2020 10-Q 2020-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.